SEP 16, 2020 10:00 AM PDT

New Crossroad: The Intersection of COVID-19 and Sepsis

Sponsored by: BD
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract
Date:  September 16, 2020
Time: 10:00am (PDT),  1:00pm (EDT)
 
Individuals infected with COVID-19 can experience mild symptoms and recover while others can experience more serious illness and may require hospital care.
 
COVID-19 clinical symptoms range from mild acute respiratory infection (ARI), severe acute respiratory infection (SARI) with progressive organ failure, sepsis and acute respiratory distress syndrome (ARDS).1 It has become clear that sepsis is a common complication in COVID-19 patients and an important risk factor for increased mortality. In a recent multicenter study, the risk factors associated with in-hospital deaths of 191 patients were analyzed and sepsis was the most frequently observed complication (100% of the non-survivors), followed by respiratory failure (98%), ARDS (93%), septic shock (70%) and heart failure (52%).2 Researchers are still investigating the pathogenic origin of sepsis in COVID-19 patients to understand whether it is directly caused by SARS-CoV-2 virus and/or a secondary source (bacterial, viral or fungal).
 
Learning Objectives
  • Compare and contrast viral sepsis with focus on sepsis symptoms caused by SARS-CoV-2
  • The role of rapid testing for COVID-19 to support blood culture stewardship
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
Loading Comments...
Show Resources